Eli Lilly and Company
LLY
$821.86
-$2.20-0.27%
| Weiss Ratings | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Good | |||
| Risk Index | Fair | |||
| Risk Grade | C- | |||
| Reward Grade | B+ | |||
| Rating Factors | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Excellent | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Fair | |||
| Volatility Index | Fair | |||
| Beta / Standard Deviation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.71 | |||
| Price History | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -11.60% | |||
| 30-Day Total Return | 2.27% | |||
| 60-Day Total Return | 3.42% | |||
| 90-Day Total Return | -8.73% | |||
| Year to Date Total Return | 5.81% | |||
| 1-Year Total Return | 9.58% | |||
| 2-Year Total Return | 157.06% | |||
| 3-Year Total Return | 214.03% | |||
| 5-Year Total Return | 593.43% | |||
| 52-Week High % Change | -15.27% | |||
| 52-Week Low % Change | 15.84% | |||
| Price | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $972.53 | |||
| 52-Week Low Price | $711.40 | |||
| 52-Week Low Price (Date) | Nov 18, 2024 | |||
| 52-Week High Price (Date) | Aug 22, 2024 | |||
| Valuation | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 740.15B | |||
| Enterprise Value | 771.22B | |||
| Price/Earnings (TTM) | 70.36 | |||
| Earnings Per Share (TTM) | 11.71 | |||
| Earnings Per Share Growth | 102.11% | |||
| Price/Earnings To Growth | 0.69 | |||
| Price/Sales (TTM) | 16.52 | |||
| Price/Book (Q) | 52.12 | |||
| Enterprise Value/Revenue (TTM) | 17.12 | |||
| Price | $821.86 | |||
| Enterprise Value/EBITDA (TTM) | 40.03 | |||
| Enterprise Value/EBIT | 44.07 | |||
| Market Cap Category | Mega Cap | |||
| Dividends and Shares | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 903.16M | |||
| Dividend Yield | 0.66% | |||
| Div. Per Share (Most Recent) | $1.50 | |||
| Dividend Per Share (TTM) | $5.40 | |||
| Payout Ratio (TTM) | 44.20% | |||
| Dividend Per Share (Most Recent) | $1.50 | |||
| Company Info | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 317 276 2000 | |||
| Address | Lilly Corporate Center Indianapolis, IN 46285 | |||
| Website | www.lilly.com | |||
| Country | United States | |||
| Year Founded | 1876 | |||
| Profitability | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 38.85% | |||
| Profit Margin | 23.51% | |||
| Management Effectiveness | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 15.33% | |||
| Return on Equity | 84.26% | |||
| Income Statement | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 45.04B | |||
| Total Revenue (TTM) | 45.04B | |||
| Revenue Per Share | $49.87 | |||
| Gross Profit (TTM) | 36.62B | |||
| EBITDA (TTM) | 19.27B | |||
| EBIT (TTM) | 17.50B | |||
| Net Income (TTM) | 10.59B | |||
| Net Income Avl. to Common (TTM) | 10.59B | |||
| Total Revenue Growth (Q YOY) | 44.68% | |||
| Earnings Growth (Q YOY) | 101.39% | |||
| EPS Diluted (TTM) | 11.71 | |||
| EPS Diluted Growth (Q YOY) | 101.85% | |||
| Balance Sheet | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 3.43B | |||
| Cash Per Share (Q) | $3.80 | |||
| Total Current Assets (Q) | 32.74B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 14.27B | |||
| Current Ratio (Q) | 1.154 | |||
| Book Value Per Share (Q) | $15.81 | |||
| Total Assets (Q) | 78.71B | |||
| Total Current Liabilities (Q) | 28.38B | |||
| Total Debt (Q) | 34.91B | |||
| Total Liabilities (Q) | 64.44B | |||
| Total Common Equity (Q) | 14.19B | |||
| Cash Flow | LLY - NYSE | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -9.30B | |||
| Cash from Financing (TTM) | 1.23B | |||
| Net Change in Cash (TTM) | 449.80M | |||
| Levered Free Cash Flow (TTM) | 1.02B | |||
| Cash from Operations (TTM) | 8.82B | |||
